卵巢上皮性肿瘤附加阑尾切除术中国专家共识(2026年版)

doi:10.11904/j.issn.1002-3070.2026.01.001

摘要/Abstract

摘要： 阑尾切除术是卵巢上皮性肿瘤(epithelial ovarian cancer,EOC)手术治疗的重要组成部分,但在临床实践中,其手术指征及切除的获益与风险尚未形成统一的诊疗意见。本共识基于现有循证医学证据,结合EOC的治疗原则和疾病特点,在我国现行诊治指南的基础上参考国际相关指南,首次系统性提出阑尾切除的指征。同时明确指出,对于外观正常的阑尾,不推荐在EOC手术中行预防性切除。本共识旨在为EOC的规范治疗及临床管理提供参考依据。

关键词: 卵巢上皮性肿瘤, 阑尾切除术, 专家共识

Abstract: Appendectomy is an important component of surgical treatment for epithelial ovarian cancer(EOC).However,in clinical practice,there is no unified diagnostic and treatment opinion on its surgical indications and the benefits and risks of resection.Based on existing evidence-based medicine,combined with the treatment principles and disease characteristics of EOC,and referencing international relevant guidelines on the basis of China′s current diagnosis and treatment guidelines,this consensus systematically proposes the indications of appendectomy for the first time and clearly states that prophylactic appendectomy is not recommended during EOC surgery for an appendix with normal appearance.This consensus aims to provide a reference basis for the standardized treatment and clinical management of EOC.

Key words: epithelial ovarian cancer, appendectomy, expert consensus

中图分类号:

R737.31

中国抗癌协会中西整合卵巢癌专业委员会. 卵巢上皮性肿瘤附加阑尾切除术中国专家共识(2026年版)[J]. 实用肿瘤学杂志, 2026, 40(1): 1-8.

Chinese Anti-Cancer Association Integrative Chinese and Western Medicine Ovarian Cancer Professional Committee. Consensus on appendectomy for epithelial ovarian cancer in China(2026 edition)[J]. Journal of Practical Oncology, 2026, 40(1): 1-8.

参考文献

1 Bray F,Laversanne M,Sung H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].CA Cancer J Clin,2024,74(3):229-263.
2 Allemani C,Matsuda T,Di Carlo V,et al.Global surveillance of trends in cancer survival 2000-14(CONCORD-3):analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries [J].Lancet,2018,391(10125):1023-1075.
3 Webb PM,Jordan SJ.Epidemiology of epithelial ovarian cancer [J].Best Pract Res Clin Obstet Gynaecol,2017,41:3-14.
4 Sonnendecker EW.Is appendicectomy mandatory in patients with ovarian carcinoma? [J].S Afr Med J,1982,62(26):978-980.
5 Ayhan A,Gultekin M,Taskiran C,et al.Routine appendectomy in epithelial ovarian carcinoma:is it necessary? [J].Obstet Gynecol,2005,105(4):719-724.
6 Sonnendecker EW,Margolius KA,Sonnendecker HE.Involvement of the appendix in ovarian epithelial cancer--an update [J].S Afr Med J,1989,76(12):667-668.
7 Altman AD,Lefas G,Power L,et al.Rate of appendiceal metastasis with non-serous epithelial ovarian cancer in manitoba [J].J Obstet Gynaecol Can,2018,40(2):180-185.
8 Rosendahl M,Haueberg Oester LA,Høgdall CK.The importance of appendectomy in surgery for mucinous adenocarcinoma of the ovary [J].Int J Gynecol Cancer,2017,27(3):430-436.
9 文图.《中国制订/修订临床诊疗指南的指导原则》由北京协和医院牵头发布 [J].中国当代医药,2022,29(10):3-4.
10 Guyatt G,D.Oxman A,Akl E,et al.GRADE指南:Ⅰ.导论——GRADE证据概要表和结果总结表 [J].中国循证医学杂志,2011,11(04):437-445.
11 Smith HF,Fisher RE,Everett ML,et al.Comparative anatomy and phylogenetic distribution of the mammalian cecal appendix[J].J Evol Biol,2009,22(10):1984-1999.
12 Agrawal M,Allin KH,Mehandru S,et al.The appendix and ulcerative colitis-an unsolved connection [J].Nat Rev Gastroenterol Hepatol,2023,20(9):615-624.
13 Girard-Madoux MJH,Gomez de Agüero M,Ganal-Vonarburg SC,et al.The immunological functions of the Appendix:An example of redundancy? [J].Semin Immunol,2018,36:31-44.
14 Vitetta L,Chen J,Clarke S.The vermiform appendix:an immunological organ sustaining a microbiome inoculum [J].Clin Sci(Lond),2019,133(1):1-8.
15 Shi F,Liu G,Lin Y,et al.Altered gut microbiome composition by appendectomy contributes to colorectal cancer [J].Oncogene,2023,42(7):530-540.
16 Wu SC,Chen WT,Muo CH,et al.Association between appendectomy and subsequent colorectal cancer development:an Asian population study [J].PLoS One,2015,10(2):e0118411.
17 Liu Z,Ma X,Zhu C,et al.Risk of colorectal cancer after appendectomy:A systematic review and meta-analysis [J].J Gastroenterol Hepatol,2023,38(3):350-358.
18 Rose PG,Abdul-Karim FW.Isolated appendiceal metastasis in early ovarian carcinoma [J].J Surg Oncol,1997,64(3):246-247.
19 Vergote I,De Brabanter J,Fyles A,et al.Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma [J].Lancet,2001,357(9251):176-182.
20 Bernard L,Chen I,Le T.Appendectomy at the time of ovarian cancer staging increases infectious complications:a National Surgical Quality Improvement Program(NSQIP)propensity score-stratified analysis [J].Int J Gynecol Cancer,2020,30(10):1542-1547.
21 Lin JE,Seo S,Kushner DM,et al.The role of appendectomy for mucinous ovarian neoplasms [J].Am J Obstet Gynecol,2013,208(1):46.e1-4.
22 Nanthamongkolkul K,Wattanapaisal P,Boonyapipat S,et al.Appendiceal tumors in patients undergoing primary surgery for mucinous ovarian tumors in a tertiary hospital,in Southern Thailand [J].Taiwan J Obstet Gynecol,2022,61(4):657-662.
23 Ozyurek ES,Karacaoglu UM,Kaya E,et al.Appendectomy in the surgical treatment of benign ovarian mucinous cystadenomas-is it necessary? [J].Ginekol Pol,2016,87(5):338-341.
24 Mukhopadhyay D,Rajab R,Nobbenhuis M,et al.Outcome of appendicectomies at surgery for mucinous ovarian neoplasms:report from a UK center and review of literature [J].Int J Gynecol Cancer,2016,26(6):1020-1026.
25 Cosyns S,De Sutter P,Tournaye H,et al.Necessity of appendectomy for mucinous borderline ovarian tumors.Systematic review [J].Arch Gynecol Obstet,2016,294(6):1283-1289.
26 Jung HJ,Park JY,Kim DY,et al.Low value of staging in detecting extraovarian occult metastasis in mucinous borderline ovarian tumors [J].Int J Gynecol Cancer,2020,30(11):1780-1783.
27 Timofeev J,Galgano MT,Stoler MH,et al.Appendiceal pathology at the time of oophorectomy for ovarian neoplasms [J].Obstet Gynecol,2010,116(6):1348-1353.
28 Kawecka W,Adamiak-Godlewska A,Lewkowicz D,et al.Diagnostic difficulties in the differentiation between an ovarian metastatic low-grade appendiceal mucinous neoplasm and primary ovarian mucinous cancer:A case report and literature review [J].Oncol Lett,2024,28(5):500.
29 Kong S,Sun J,Sui X,et al.Clinical characteristics and survival outcomes in patients with primary ovarian carcinoid:A historical cohort study [J].Acta Obstet Gynecol Scand,2023,102(7):935-941.
30 Habib M,Azam Khalil K,Tayyab Z,et al.Performing routine appendectomy in mucinous borderline ovarian tumours:Anexperience of 15 years from a cancer centre [J].Cureus,2024,16(7):e65580.
31 Singh MP.A general overview of mucocele of appendix [J].J Family Med Prim Care,2020,9(12):5867-5871.
32 Kim JJ,Lim YS,Shin JH,et al.Relative adrenal insufficiency after cardiac arrest:impact on postresuscitation disease outcome [J].Am J Emerg Med,2006,24(6):684-688.
33 Yagur Y,Choi S,Robertson JA,et al.Should an interval appendicectomy be performed by a minimally invasive gynaecologist? [J].Int J Womens Health,2024,16:2311-2318.
34 Peeyananjarassri K,Nanthamongkolkul K,Jiamset I,et al.Impact of appendectomy of a grossly normal appendix on the survival outcomes of mucinous ovarian carcinomas in a tertiary hospital[J].Int J Gynaecol Obstet,2023,162(1):317-324.
35 Albloshi A,Fadare O.Revisiting the necessity for routine appendectomies in mucinous neoplasms of the ovary:An evaluation of 460 mucinous ovarian tumors [J].Ann Diagn Pathol,2022,59:151950.
36 Kurnit KC,Frumovitz M.Primary mucinous ovarian cancer:options for surgery and chemotherapy [J].Int J Gynecol Cancer,2022,32(11):1455-1462.
37 Cheng A,Li M,Kanis MJ,et al.Is it necessary to perform routine appendectomy for mucinous ovarian neoplasms? A retrospective study and meta-analysis [J].Gynecol Oncol,2017,144(1):215-222.
38 Bourdel N,Huchon C,Abdel Wahab C,etal.Borderline ovarian tumors:Guidelines from the French national college of obstetricians and gynecologists(CNGOF)[J].Eur J Obstet Gynecol Reprod Biol,2021,256:492-501.
39 Ionescu S,Marincas M,Madge OL,et al.Ovarian causes of pseudomyxoma peritonei(PMP)-A literature review [J].Cancers(Basel),2024,16(8):1446.
40 Tsoukalas N,Tsapakidis K,Tolia M,et al.Pseudomyxoma peritonei:A challenging clinical diagnosis.Case report and review of the literature [J].Cancer Diagn Progn,2024,4(2):198-203.
41 Agrawal AK,Bobiński P,Grzebieniak Z,et al.Pseudomyxoma peritonei originating from urachus-case report and review of the literature [J].Curr Oncol,2014,21(1):e155-165.
42 Köhler F,Rosenfeldt M,Matthes N,et al.[Incidental finding of mucinous neoplasia of the appendix:Treatment strategies] [J].Chirurg,2019,90(3):194-201.
43 McKenney JK,Soslow RA,Longacre TA.Ovarian mature teratomas with mucinous epithelial neoplasms:morphologic heterogeneity and association with pseudomyxoma peritonei [J].Am J Surg Pathol,2008,32(5):645-655.
44 谢加贤,丁凯,宁北芳.腹膜假性黏液瘤22例临床分析 [J].临床消化病杂志,2025,37(02):113-117.
45 张颐,张师前,沈文静,等.消化道恶性肿瘤卵巢转移诊治中国专家共识(2023年版)[J].中国实用妇科与产科杂志,2023,39(08):817-823.
46 Rouzbahman M,Chetty R.Mucinous tumours of appendix and ovary:an overview and evaluation of current practice [J].J Clin Pathol,2014,67(3):193-197.
47 Chua TC,Moran BJ,Sugarbaker PH,et al.Early-and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy [J].J Clin Oncol,2012,30(20):2449-2456.
48 Carr NJ,Cecil TD,Mohamed F,et al.A Consensus for Classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia:The results of the Peritoneal Surface Oncology Group International(PSOGI)modified Delphi process [J].Am J Surg Pathol,2016,40(1):14-26.
49 Hackshaw A,Gershenson D,Ledermann J.Mucinous ovarian carcinoma [J].N Engl J Med,2019,381(1):e3.
50 Khalid S,El-Masry N,Goldin RD,et al.Primary lesions of the appendix in patients undergoing surgery for gynecological tumors [J].Int J Surg Pathol,2025,33(7):1615-1623.
51 Lavecchia M,Dubey A,Jimenez W,et al.Intraoperative predictors of appendiceal abnormalities in patients with mucinous ovarian neoplasms [J].Int J Gynaecol Obstet,2024,164(1):249-254.
52 Govaerts K,Lurvink RJ,De Hingh I,et al.Appendiceal tumours and pseudomyxoma peritonei:Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment [J].Eur J Surg Oncol,2021,47(1):11-35.
53 张国庆,郑重,王玉婷,等.阑尾黏液性肿瘤的CT表现及病理基础 [J].中国CT和MRI杂志,2025,23(06):165-167.
54 Shaib WL,Assi R,Shamseddine A,et al.Appendiceal mucinous neoplasms:Diagnosis and management [J].Oncologist,2017,22(9):1107-1116.
55 Vaira M,Robella M,Guaglio M,et al.Diagnostic and therapeutic algorithm for appendiceal tumors and pseudomyxoma peritonei:A consensus of the peritoneal malignancies oncoteam of the Italian Society of Surgical Oncology(SICO)[J].Cancers(Basel),2023,15(3):728.
56 JayaprakasamVS,Paroder V,Schöder H.Variants and pitfalls in PET/CT imaging of gastrointestinal cancers [J].Semin Nucl Med,2021,51(5):485-501.
57 Guo AT,Song X,Wei LX,et al.Histological origin of pseudomyxoma peritonei in Chinese women:clinicopathology and immunohistochemistry [J].World J Gastroenterol,2011,17(30):3531-3537.
58 Pinto PB,Derchain SF,Andrade LA.Metastatic mucinous carcinomas in the ovary:a practical approach to diagnosis related to gross aspects and to immunohistochemical evaluation [J].Int J Gynecol Pathol,2012,31(4):313-318.
59 Zhang PJ,Shah M,Spiegel GW,et al.Cytokeratin 7 immunoreactivity in rectal adenocarcinomas [J].Appl Immunohistochem Mol Morphol,2003,11(4):306-310.
60 Vang R,Gown AM,Wu LS,et al.Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary:comparison with CK20 and correlation with coordinate expression of CK7 [J].Mod Pathol,2006,19(11):1421-1428.
61 Berg KB,Schaeffer DF.SATB2 as an Immunohistochemical marker for colorectal adenocarcinoma:a concise review of benefits and pitfalls [J].Arch Pathol Lab Med,2017,141(10):1428-1433.
62 Ribero L,Santía MC,Borchardt K,et al.Surgical site infection prevention bundle in gynecology oncology surgery:a key element in the implementation of an enhanced recovery after surgery(ERAS)program [J].Int J Gynecol Cancer,2024,34(9):1445-1453.
63 Tiselius C,Kindler C,Shetye J,et al.Computed tomography follow-up assessment of Patients with low-grade appendiceal mucinous neoplasms:evaluation of risk for pseudomyxoma peritonei [J].Ann Surg Oncol,2017,24(7):1778-1782.
64 Bucher P,Mathe Z,Demirag A,et al.Appendix tumors in the era of laparoscopicappendectomy [J].Surg Endosc,2004,18(7):1063-1066.

[1]	中国抗癌协会中西整合卵巢癌专业委员会, 卵巢癌合并直肠内瘘诊治中国专家共识制定专家组. 卵巢癌合并直肠内瘘诊治中国专家共识(2025年版)[J]. 实用肿瘤学杂志, 2025, 39(6): 457-463.
[2]	中国抗癌协会中西整合卵巢癌专业委员会, 妇科手术肠道准备中国专家共识制定专家组. 妇科手术肠道准备中国专家共识(2025年版)[J]. 实用肿瘤学杂志, 2025, 39(5): 363-371.
[3]	孙文洲;隋丽华;于丽波. 细胞周期素D1在卵巢上皮性肿瘤中表达及临床意义[J]. 实用肿瘤学杂志, 2000, 14(03): 191-192.